University of Copenhagen researchers have developed a prototype patch for treating plaque psoriasis, which may simplify ...

Continued to advance three clinical programs in immune-mediated diseases: The Phase 3 ONWARD program for ESK-001 in moderate-to-severe plaque psoriasis consists of two parallel 24-week global Phase 3 ...

Successful go-public transaction and over $475 million raised this year provides cash runway through multiple clinical ...

Researchers at Case Western Reserve University have identified a new target to treat atherosclerosis, a condition where ...

However, for people with risks for heart disease, these warning signals can have a negative consequence: they can increase ...

Researchers at the University of Massachusetts Amherst have invented a new, sprayable delivery system for psoriasis ...

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritisTwo trials for ...